Hypoxia Imaging and Biological Evaluation of the Radiosensitizing Effect of Oleanolic Acid

Background and Purpose The aim of this study was to evaluate the radiosensitizing effect of oleanolic acid (OA) on C6 rat glioma and the changes in tumor biology during radiosensitization therapy on 18F-fluoromisonidazole (18F-FMISO) positron emission tomography/computed tomography (PET/CT). Methods The radiosensitizing effect of OA on C6 tumors was assessed in vivo by measuring the tumor inhibitory rate and rat survival time. Meanwhile, rats with C6 tumors were imaged with 18F-FMISO PET/CT during radiosensitization therapy. Tumor-to-muscle ratio (TMR) of 18F-FMISO maximum uptake was calculated by region of interest analysis. Changes in tumor biology after therapy were assessed with immunohistochemical staining. 18F-FMISO uptake was analyzed in relation to expression of tumor biomarkers including hypoxia-inducible factor (HIF)-1α, glucose transporter (Glut-1), the proliferation antigen Ki67, tumor suppressor P53, and microvessel density (MVD). Results The results showed that OA combined with radiation inhibited the growth rates of tumors and prolonged the survival period of tumor-bearing rats effectively (χ2 = 12.5, p < 0.01). 18F-FMISO PET/CT indicated decreases in hypoxia after radiosensitization therapy. Statistical differences were observed in TMR of the irradiation group and OA combined with irradiation group (t = 3.32, p < 0.05). HIF-1α, Glut-1, Ki67, P53, and MVD expressions in tumors were downregulated by OA combined with radiation as well as with radiation alone. Additionally, there was a significant positive linear correlation between TMR and HIF-1α, Glut-1, Ki67, P53, and MVD. Conclusions These results suggest that OA has a radiosensitizing effect on C6 tumors in terms of tumor volume inhibition, survival extension, and multiple poor prognosis biological markers downregulation. 18F-FMISO PET/CT can be of value for tumor biology noninvasive capture and radiosensitization response evaluation.

[1]  W. Hager,et al.  and s , 2019, Shallow Water Hydraulics.

[2]  R. Sarpong,et al.  Bio-inspired synthesis of xishacorenes A, B, and C, and a new congener from fuscol† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc02572c , 2019, Chemical science.

[3]  Astrid Zimmermann,et al.  Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation , 2017, Radiation Oncology.

[4]  Xinke Zhang,et al.  Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma , 2017, BMC Cancer.

[5]  T. Fukutomi,et al.  Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions. , 2017, Biomedical reports.

[6]  W. Guo,et al.  Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases , 2017, Journal of Cancer.

[7]  M. Duffy,et al.  Mutant p53 as a target for cancer treatment. , 2017, European journal of cancer.

[8]  S. Samarajiwa,et al.  Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity , 2017, Genes & development.

[9]  Richard Pötter,et al.  Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET , 2017, Molecular Imaging and Biology.

[10]  S. Carlin,et al.  18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy , 2017, The Journal of Nuclear Medicine.

[11]  M. Masullo,et al.  Oleanane derivatives for pharmaceutical use: a patent review (2000-2016) , 2017, Expert opinion on therapeutic patents.

[12]  W. Gu,et al.  Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia‐inducible factors HIF1α and HIF2α , 2017, Clinical and experimental pharmacology & physiology.

[13]  A. Badowska-Kozakiewicz,et al.  Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes , 2016, Archives of medical science : AMS.

[14]  N. Can,et al.  Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time , 2016, Archives of medical science : AMS.

[15]  Yongfeng Guo,et al.  NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  M. Nowicki,et al.  The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors. , 2016, Microvascular research.

[17]  Y. Tu.  Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture). , 2016, Angewandte Chemie.

[18]  Bram Boeckx,et al.  Tumor hypoxia causes DNA hypermethylation by reducing TET activity , 2016, Nature.

[19]  G. A. Gutiérrez-Rebolledo,et al.  Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damage. , 2016, Asian Pacific journal of tropical medicine.

[20]  R. Chirla,et al.  PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer. , 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[21]  Huiqin Xu,et al.  Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas , 2015, Nuclear medicine communications.

[22]  Yunfeng Zheng,et al.  Bioactive constituents of oleanane-type triterpene saponins from the roots of Glycyrrhiza glabra , 2014, Journal of Asian natural products research.

[23]  岡本祥三.  High reproducibility of tumor hypoxia evaluated by 18 F-fluoromisonidazole PET for head and neck cancer. , 2014 .

[24]  Juan Wang,et al.  Radiosensitizing effect of oleanolic acid on tumor cells through the inhibition of GSH synthesis in vitro. , 2013, Oncology reports.

[25]  Huiqin Xu,et al.  Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography , 2013, Nuclear medicine communications.

[26]  Keiichi Magota,et al.  High Reproducibility of Tumor Hypoxia Evaluated by 18F-Fluoromisonidazole PET for Head and Neck Cancer , 2013, The Journal of Nuclear Medicine.

[27]  W. Marsden.  I and J , 2012 .

[28]  V. Ruíz-Gutiérrez,et al.  Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid , 2012, European Journal of Nutrition.

[29]  J. Overgaard,et al.  Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode , 2010, Acta oncologica.

[30]  A. Carvalho,et al.  Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma , 2010, Molecules.

[31]  Roland Bares,et al.  Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer , 2007 .

[32]  Roland Bares,et al.  Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  Matthias Reimold,et al.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.